Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Survey: Compliance Programs Don’t Hurt Bottom Line, But Face Other Hurdles

This article was originally published in The Gray Sheet

Executive Summary

Nine out of 10 device and diagnostic firms responding to a survey say implementing a compliance program based on the 1AdvaMed Code of Ethics did not hurt their company's bottom line, including 10% who say their compliance program increased revenue

You may also be interested in...

Waxman’s Oversight Committee Looks Into Drug-Eluting Stents

The House Committee on Oversight and Government Reform is requesting information on the off-label use and marketing of drug-eluting stents

Device Firms Are Adopting And Promoting Ethics Standards, Survey Finds

A new survey suggests that medical device firms are complying with industry standards written to prevent fraudulent sales and marketing practices. Roughly 75% of surveyed companies said they post their compliance programs on the company website

Common Regulatory Starting Point Means EU-UK Are On Track For Medtech MRA, Say German Firms

With Brexit less than a month old, Germany’s medtech industry has renewed its push for an MRA between the EU and UK in medtech regulation.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts